VISIOTACT Trademark

Trademark Overview


On Monday, April 15, 2013, a trademark application was filed for VISIOTACT with the United States Patent and Trademark Office. The USPTO has given the VISIOTACT trademark a serial number of 79131636. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, April 14, 2023. This trademark is owned by NEXINNOV. The VISIOTACT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary products, namely, anti-glaucoma agents, antiviral agents, antioxidants, antiparasitics, antifungals, corticosteroids, anti-inflammants, analgesics, antipyretics, antihistamines, antibiotics, betablockers, antineoplastic agents, immunosuppressive agents; chemical preparations for medical or pharmaceutical use, namely, for Age-related Macular Degeneration, diabetic retinopathy, cataract, retinis pigmentosa, glaucoma, macular edema, ocular hypertension, retinal degeneration uveitis, vascular disease, proliferative disorders, retinoblastome, intraocular lymphoid tumors, dry eyes; medicinal herbs, vitamins, mineral supplements, nutritional supplements for medical use; pharmaceutical products used in ophthalmology; formulations based on amino acids for medical or veterinary purposes; dietetic substances for medical use, namely, dietetic sugar for medical use; food supplements based on natural flowers and plants for medical use
visiotact

General Information


Serial Number79131636
Word MarkVISIOTACT
Filing DateMonday, April 15, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateFriday, April 14, 2023
Registration Number4549714
Registration DateTuesday, June 17, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 1, 2014

Trademark Statements


Goods and ServicesPharmaceutical and veterinary products, namely, anti-glaucoma agents, antiviral agents, antioxidants, antiparasitics, antifungals, corticosteroids, anti-inflammants, analgesics, antipyretics, antihistamines, antibiotics, betablockers, antineoplastic agents, immunosuppressive agents; chemical preparations for medical or pharmaceutical use, namely, for Age-related Macular Degeneration, diabetic retinopathy, cataract, retinis pigmentosa, glaucoma, macular edema, ocular hypertension, retinal degeneration uveitis, vascular disease, proliferative disorders, retinoblastome, intraocular lymphoid tumors, dry eyes; medicinal herbs, vitamins, mineral supplements, nutritional supplements for medical use; pharmaceutical products used in ophthalmology; formulations based on amino acids for medical or veterinary purposes; dietetic substances for medical use, namely, dietetic sugar for medical use; food supplements based on natural flowers and plants for medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNEXINNOV
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR

Party NameNEXINNOV
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR

Party NameNEXINNOV
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events


Event DateEvent Description
Wednesday, July 31, 2013ASSIGNED TO EXAMINER
Thursday, June 27, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB
Saturday, June 29, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 3, 2013APPLICATION FILING RECEIPT MAILED
Monday, August 5, 2013NON-FINAL ACTION WRITTEN
Tuesday, August 6, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, August 7, 2013REFUSAL PROCESSED BY MPU
Wednesday, August 7, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, August 24, 2013REFUSAL PROCESSED BY IB
Friday, February 7, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 12, 2014ASSIGNED TO LIE
Wednesday, February 19, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 19, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 12, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Friday, February 21, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, February 22, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 12, 2014NOTICE OF PUBLICATION
Wednesday, March 12, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, March 28, 2014NOTIFICATION PROCESSED BY IB
Tuesday, April 1, 2014PUBLISHED FOR OPPOSITION
Tuesday, June 17, 2014REGISTERED-PRINCIPAL REGISTER
Wednesday, September 17, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, November 14, 2014FINAL DISPOSITION PROCESSED
Friday, November 14, 2014FINAL DISPOSITION NOTICE SENT TO IB
Friday, December 19, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, February 26, 2021CANCELLED SECTION 71
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Tuesday, February 22, 2022INVALIDATION PROCESSED
Tuesday, February 22, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sunday, March 20, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Saturday, November 11, 2023DEATH OF INTERNATIONAL REGISTRATION
Saturday, November 11, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Wednesday, May 8, 2024UNDELIVERABLE MAIL - NO ACTION TAKEN